US Stock MarketDetailed Quotes
JAGX Jaguar Health
- 1.0000
- -0.0300-2.91%
Close Nov 26 16:00 ET
- 1.0500
- +0.0500+5.00%
Post 20:01 ET
11.80MMarket Cap-276P/E (TTM)
1.0400High0.9925Low79.10KVolume1.0200Open1.0300Pre Close79.63KTurnover0.74%Turnover RatioLossP/E (Static)11.80MShares24.300052wk High0.87P/B10.66MFloat Cap0.900052wk Low--Dividend TTM10.66MShs Float100075500.0000Historical High--Div YieldTTM4.61%Amplitude0.9000Historical Low1.0060Avg Price1Lot Size
Jaguar Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.49%3.11M | 1.68%2.72M | 19.22%2.35M | -18.36%9.76M | -29.45%2.3M | -10.70%2.81M | -8.39%2.68M | -24.88%1.97M | 175.80%11.96M | 56.73%3.26M |
| Operating revenue | 8.94%4.02M | 4.77%3.63M | 20.26%3.42M | -9.40%13.61M | -7.60%3.61M | -4.82%3.69M | -8.27%3.46M | -17.81%2.84M | -4.45%15.02M | 30.23%3.91M |
| Cost of revenue | 5.25%541K | -13.03%427K | 24.64%430K | 0.89%2.04M | 38.79%687K | -16.15%514K | 7.68%491K | -24.18%345K | -13.46%2.02M | 5.54%495K |
| Gross profit | 11.66%2.57M | 4.99%2.29M | 18.07%1.92M | -22.27%7.72M | -41.66%1.61M | -9.38%2.3M | -11.36%2.19M | -25.02%1.63M | 396.35%9.94M | 71.63%2.77M |
| Operating expense | -11.34%9.83M | -7.74%9.49M | -11.65%10.14M | -6.11%41.64M | -2.78%8.8M | -10.83%11.09M | 15.02%10.29M | -17.61%11.47M | 7.98%44.35M | -27.20%9.05M |
| Selling and administrative expenses | 15.60%5.79M | -2.86%5.84M | -13.04%5.82M | -13.69%23.05M | 12.57%5.34M | -22.92%5.01M | -7.44%6.01M | -25.41%6.7M | 2.72%26.71M | -31.81%4.74M |
| -Selling and marketing expense | 80.22%1.15M | -15.38%743K | -29.83%661K | -36.31%3.28M | -29.64%826K | -52.03%637K | -34.28%878K | -66.77%942K | -42.04%5.16M | -48.91%1.17M |
| -General and administrative expense | 6.18%4.64M | -0.72%5.1M | -10.29%5.16M | -8.28%19.77M | 26.47%4.51M | -15.43%4.37M | -0.48%5.13M | -6.33%5.76M | 26.00%21.55M | -23.36%3.57M |
| Research and development costs | -33.51%4.04M | -14.59%3.65M | -9.70%4.31M | 5.38%18.6M | -19.67%3.46M | 2.37%6.08M | 74.50%4.28M | -3.44%4.78M | 17.03%17.65M | -21.36%4.31M |
| Operating profit | 17.36%-7.26M | 11.17%-7.2M | 16.56%-8.22M | 1.44%-33.92M | -14.32%-7.19M | 11.21%-8.79M | -25.05%-8.1M | 16.24%-9.85M | 11.92%-34.42M | 41.91%-6.29M |
| Net non-operating interest income expense | 132.40%162K | 103.13%108K | 71.99%-611K | 49.84%-6.38M | 90.58%-248K | 81.69%-500K | -36.16%-3.45M | 48.00%-2.18M | -26.53%-12.72M | -8.26%-2.63M |
| Non-operating interest expense | ---- | ---- | -71.99%611K | -49.84%6.38M | ---- | ---- | ---- | -48.00%2.18M | 51.09%12.72M | 8.26%2.63M |
| Total other finance cost | -132.40%-162K | -103.13%-108K | ---- | ---- | ---- | --500K | --3.45M | ---- | ---- | ---- |
| Other net income (expense) | -311.21%-2.92M | -244.97%-2.54M | -46.09%-542K | -27.21%-1.6M | -372.53%-1.88M | 7,583.33%1.38M | -96.27%-736K | 83.26%-371K | 63.79%-1.26M | 164.72%688K |
| Gain on sale of security | -37.66%-3.09M | -137.53%-1.81M | -462.95%-2.02M | -25,525.00%-5.13M | -161.90%-1.76M | -1,375.00%-2.24M | -207.48%-762K | -54.08%-359K | 98.98%-20K | -114.01%-672K |
| Special income (charges) | --0 | --0 | --1.25M | 252.08%3.33M | ---371K | --3.7M | --0 | --0 | -190.44%-2.19M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --371K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---1.25M | -269.04%-3.7M | --0 | ---3.7M | ---- | ---- | 190.44%2.19M | --0 |
| Other non- operating income (expenses) | 340.00%168K | -2,903.85%-729K | 2,050.00%234K | -78.95%200K | -81.18%256K | 55.70%-70K | 102.40%26K | -101.44%-12K | 224.18%950K | 281.58%1.36M |
| Income before tax | -26.78%-10.02M | 21.67%-9.63M | 24.43%-9.37M | 13.42%-41.9M | -13.08%-9.31M | 37.31%-7.9M | -30.89%-12.29M | 31.75%-12.4M | 7.99%-48.4M | 42.51%-8.23M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -26.78%-10.02M | 21.67%-9.63M | 24.43%-9.37M | 13.42%-41.9M | -13.08%-9.31M | 37.31%-7.9M | -30.89%-12.29M | 31.75%-12.4M | 7.99%-48.4M | 42.51%-8.23M |
| Net income continuous Operations | -26.78%-10.02M | 21.67%-9.63M | 24.43%-9.37M | 13.42%-41.9M | -13.08%-9.31M | 37.31%-7.9M | -30.89%-12.29M | 31.75%-12.4M | 7.99%-48.4M | 42.51%-8.23M |
| Minority interest income | -32.54%-167K | 3.55%-136K | 27.18%-142K | 36.13%-601K | 78.65%-139K | -41.57%-126K | -513.04%-141K | -9.55%-195K | -18,720.00%-941K | -12,920.00%-651K |
| Net income attributable to the parent company | -26.69%-9.85M | 21.88%-9.49M | 24.39%-9.23M | 12.97%-41.3M | -20.96%-9.17M | 37.88%-7.78M | -29.71%-12.15M | 32.16%-12.2M | 9.77%-47.45M | 47.03%-7.58M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -26.69%-9.85M | 21.88%-9.49M | 24.39%-9.23M | 12.97%-41.3M | -20.96%-9.17M | 37.88%-7.78M | -29.71%-12.15M | 32.16%-12.2M | 9.77%-47.45M | 47.03%-7.58M |
| Basic earnings per share | 95.33%-1.05 | 90.23%-4.04 | 97.49%-3.6 | 95.05%-107.4 | 96.40%-7.4946 | 95.75%-22.5 | 92.14%-41.35 | 89.65%-143.4 | 57.94%-2.17K | 83.27%-208.4525 |
| Diluted earnings per share | 95.33%-1.05 | 90.23%-4.04 | 97.49%-3.6 | 95.05%-107.4 | 96.40%-7.4946 | 95.75%-22.5 | 92.14%-41.35 | 89.65%-143.4 | 57.94%-2.17K | 84.35%-208.4525 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data